If you are not registered you may register by using the following link:

New Registrations

Address questions about passwords, submissions, testing, registration to:

Mohammed Nayel
Project Manager
Contractor: NCI Chemotherapeutic Agents Repository
Fisher BioServices
Email: mohammed.nayel@nih.gov
Phone: 240-686-4720
Forgot Password?

Compound Submission Application Log In


This application is now disabled.
An unknown error has occured. A server error has occured. Any attempt to login will fail.Unable to Modify News Item gov.cancer.dtp.compsub.exception.ServicesException Closed Connection {SELECT t0.NEWSID, t0.DESCRIPTION, t0.MODIFIED, t0.NEWSORDER, t0.TITLE FROM COMPSUBDEV.DTPNEWS t0 ORDER BY t0.NEWSORDER DESC} [code=17008, state=08003]

Registered Users Login:

*** Warning ***

You are accessing a U.S. Government information system, which includes.

  1. this computer,
  2. this computer network,
  3. all computers connected to this network, and
  4. all devices and storage media attached to this network or to a computer on this network.

This information system is provided for U.S. Government-authorized use only. Unauthorized or improper use of this system may result in disciplinary action, as well as civil and criminal penalties.

By using this information system, you understand and consent to the following: You have no reasonable expectation of privacy regarding any communications or data transiting or stored on this information system. At any time, and for any lawful Government purpose, the government may monitor, intercept, and search and seize any communication or data transiting or stored on this information system. Any communication or data transiting or stored on this information system may be disclosed or used for any lawful Government purpose.

Nothing in the preceding language overrides or modifies in any way the terms of the Discreet Screening Agreement

If you have never used our online compound submission application, you will need to register with us as an online supplier, even if you have submitted compounds to us through another method before.

Structures submitted through the compound submission application will be considered for testing in our in vitro anticancer screen. .